Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356638![]() (1-(3-(9H-carbazol- 9-yl)-2- hydroxypropyl) tetrahy...) | PDB UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 299 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356641![]() (1-(3-(3,6-difluoro- 9H-carbazol-9-yl)-2- hydroxypr...) | PDB UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 1.11E+3 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356645![]() (1-(3-(3,6-difluoro- 9H-carbazol-9-yl)-2- hydroxypr...) | PDB UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 171 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356661![]() (1-cyclobutyl-3-(3- (3,6-difluoro-9H- carbazol-9-yl...) | PDB UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 816 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356669![]() (1-(3-(9H-carbazol- 9-yl)-2- hydroxypropyl)imid- az...) | PDB UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 325 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356688![]() (1-cyclopentyl-3-(3- (3,6-difluoro-9H- carbazol-9-y...) | PDB UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 621 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356697![]() (1-(3-(3,6-difluoro- 9H-carbazol-9-yl)-2- hydroxypr...) | PDB UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 833 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356699![]() (1-(3-(9H-carbazol- 9-yl)-2- hydroxypropyl)-3- ethy...) | PDB UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 568 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356919![]() (1-(3-(3,6-difluoro- 9H-carbazol-9-yl)-2- hydroxypr...) | PDB UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 373 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356920![]() ((S)-1-((R)-3-(3,6- difluoro-9H- carbazol-9-yl)-2- ...) | PDB UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 830 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356927![]() (1-(3-(3,6-difluoro- 9H-carbazol-9-yl)-2- hydroxypr...) | PDB UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 52 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356929![]() (1-(3-(3,6-difluoro- 9H-carbazol-9-yl)-2- hydroxy-2...) | PDB UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 618 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356948![]() ((S)-1-((S)-3-(9H- carbazol-9-yl)-2- hydroxy-2- met...) | PDB UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 309 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356949![]() (4-(3-(3,6-difluoro- 9H-carbazol-9-yl)-2- hydroxy-2...) | PDB UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 1.06E+3 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356965![]() (1-(3-(9H-carbazol- 9-yl)-2- hydroxypropyl)-3- meth...) | PDB UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 331 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356967![]() ((S)-1-((R)-3-(9H- carbazol-9-yl)-2- hydroxypropyl)...) | PDB UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 748 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356970![]() ((S)-1-((R)-3-(3,6- difluoro-9H- carbazol-9-yl)-2- ...) | PDB UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 895 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356976![]() ((R)-1-((R)-3-(9H- carbazol-9-yl)-2- hydroxypropyl)...) | PDB UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 280 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356977![]() (1-(3-(9H-carbazol- 9-yl)-2- hydroxypropyl)-6- meth...) | PDB UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 541 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356981![]() ((R)-1-((S)-3-(9H- carbazol-9-yl)-2- hydroxypropyl)...) | PDB UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 838 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356983![]() ((R)-1-((R)-3-(3,6- difluoro-9H- carbazol-9-yl)-2- ...) | PDB UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 397 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356984![]() (1-(3-(9H-carbazol- 9-yl)-2-hydroxy-2- methylpropyl...) | PDB UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 523 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356991![]() (1-(3-(9H-carbazol- 9-yl)-2- hydroxypropyl) pyrroli...) | PDB UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 288 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356633![]() (1-(3-(9H-carbazol-9-yl)-2-hydroxypropyl)piperidin-...) | PDB UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 171 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356636![]() (US10214507, Compound 71) | PDB UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 188 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356646![]() (1-(3-(3,6-difluoro- 9H-carbazol-9-yl)-2- hydroxypr...) | PDB UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 625 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356658![]() (1-(3-(3,6-difluoro- 9H-carbazol-9-yl)-2- hydroxypr...) | PDB UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 120 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356676![]() (1-(3-(3,6-difluoro- 9H-carbazol-9-yl)-2- hydroxy-2...) | PDB UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 317 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356711![]() (US10214507, Compound 101) | PDB UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 417 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356712![]() (1-(3-(3,6-difluoro- 9H-carbazol-9-yl)-2- hydroxy-2...) | PDB UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 625 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356719![]() (1-(3-(3,6-difluoro- 9H-carbazol-9-yl)-2- hydroxy-2...) | PDB UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 760 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356723![]() (1-(3-(3,6-difluoro- 9H-carbazol-9-yl)-2- hydroxy-2...) | PDB UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 1.22E+3 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356725![]() (1-(3-(3,6-difluoro- 9H-carbazol-9-yl)-2- hydroxypr...) | PDB UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 342 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356726![]() ((1R,4S)-2-((S)-3- (9H-carbazol-9-yl)- 2-hydroxypro...) | PDB UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 750 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356728![]() (1-(3-(3,6-difluoro- 9H-carbazol-9-yl)-2- hydroxy-2...) | PDB UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 484 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356934![]() ((S)-1-((R)-3-(9H- carbazol-9-yl)-2- hydroxypropyl)...) | PDB UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 188 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356951![]() (1-(3-(3,6-difluoro- 9H-carbazol-9-yl)-2- hydroxypr...) | PDB UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 329 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356979![]() ((S)-1-((S)-3-(9H- carbazol-9-yl)-2- hydroxypropyl)...) | PDB UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 1.13E+3 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356639![]() (1-(3-(3,6-difluoro- 9H-carbazol-9-yl)-2- hydroxypr...) | PDB UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 389 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356644![]() (1-(3-(3,6-difluoro- 9H-carbazol-9-yl)-2- hydroxypr...) | PDB UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 719 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356649![]() (1-(3-(3,6-difluoro- 9H-carbazol-9-yl)-2- hydroxy-2...) | PDB UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 527 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356659![]() (1-(3-(3,6-difluoro- 9H-carbazol-9-yl)-2- hydroxy-2...) | PDB UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 1.11E+3 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356663![]() (1-(3-(3,6-difluoro- 9H-carbazol-9-yl)-2- hydroxypr...) | PDB UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 288 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356671![]() (US10214507, Compound 85) | PDB UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 667 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356679![]() (1-(3-(3,6-difluoro- 9H-carbazol-9-yl)-2- hydroxypr...) | PDB UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 547 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356685![]() (3-cyclohexyl-1-(3- (3,6-difluoro-9H- carbazol-9-yl...) | PDB UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 1.04E+3 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356698![]() (1-(3-(3,6-difluoro- 9H-carbazol-9-yl)-2- hydroxy-2...) | PDB UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 1.05E+3 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356704![]() (1-(3-(3,6-difluoro- 9H-carbazol-9-yl)-2- hydroxypr...) | PDB UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 422 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356705![]() (1-(3-(9H-carbazol- 9-yl)-2- hydroxypropyl)-3- isop...) | PDB UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 269 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356715![]() (3-(3-(3,6-difluoro- 9H-carbazol-9-yl)-2- hydroxypr...) | PDB UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 940 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356716![]() (1-(3-(3,6-difluoro- 9H-carbazol-9-yl)-2- hydroxy-2...) | PDB UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 678 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356717![]() (US10214507, Compound 104) | PDB UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 115 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356924![]() ((S)-1-((R)-3-(9H- carbazol-9-yl)-2- hydroxypropyl)...) | PDB UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 470 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356937![]() (3-cyclobutyl-1-(3- (3,6-difluoro-9H- carbazol-9-yl...) | PDB UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 204 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356941![]() (3-cyclobutyl-1-(3- (3,6-difluoro-9H- carbazol-9-yl...) | PDB UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 1.36E+3 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356942![]() ((R)-1-((R)-3-(9H- carbazol-9-yl)-2- hydroxypropyl)...) | PDB UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 210 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356956![]() (1-(3-(3,6-difluoro- 9H-carbazol-9-yl)-2- hydroxypr...) | PDB UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 716 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356635![]() (1-(3-(9H-carbazol- 9-yl)-2- hydroxypropyl)-3- meth...) | PDB UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 736 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356642![]() (1-(3-(3,6-difluoro- 9H-carbazol-9-yl)-2- hydroxy-2...) | PDB UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 536 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356653![]() (1-(3-(3,6-difluoro- 9H-carbazol-9-yl)-2- hydroxypr...) | PDB UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 300 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356654![]() (1-cyclobutyl-3-(3- (3,6-difluoro-9H- carbazol-9-yl...) | PDB UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 440 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356670![]() (1-(3-(3,6-difluoro- 9H-carbazol-9-yl)-2- hydroxypr...) | PDB UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 463 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356672![]() (1-(3-(3,6-difluoro- 9H-carbazol-9-yl)-2- hydroxypr...) | PDB UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 417 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356683![]() (3-cyclohexyl-1-(3- (3,6-difluoro-9H- carbazol-9-yl...) | PDB UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 379 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356694![]() (1-(3-(3,6-difluoro- 9H-carbazol-9-yl)-2- hydroxypr...) | PDB UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 332 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356702![]() (1-(3-(3,6-difluoro- 9H-carbazol-9-yl)-2- hydroxy-2...) | PDB UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 824 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356720![]() ((1R,4S)-2-((R)-3- (3,6-difluoro-9H- carbazol-9-yl)...) | PDB UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 54 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356724![]() ((1R,4S)-2-((R)-3- (9H-carbazol-9-yl)- 2-hydroxypro...) | PDB UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 89 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356922![]() ((R)-1-((R)-3-(9H- carbazol-9-yl)-2- hydroxypropyl)...) | PDB UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 95 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356923![]() (1-(3-(3,6-difluoro- 9H-carbazol-9-yl)-2- hydroxypr...) | PDB UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 1.03E+3 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356925![]() (1-(3-(3,6-difluoro- 9H-carbazol-9-yl)-2- hydroxy-2...) | PDB UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 1.06E+3 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356936![]() ((R)-1-((R)-3-(9H- carbazol-9-yl)-2- hydroxypropyl)...) | PDB UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 120 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356944![]() ((S)-1-((R)-3-(9H- carbazol-9-yl)-2- hydroxypropyl)...) | PDB UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 263 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356945![]() (1-(3-(3,6-difluoro- 9H-carbazol-9-yl)-2- hydroxy-2...) | PDB UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 808 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356946![]() ((R)-1-((S)-3-(9H- carbazol-9-yl)-2- hydroxy-2- met...) | PDB UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 311 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356973![]() (1-(3-(9H-carbazol- 9-yl)-2- hydroxypropyl)-5- meth...) | PDB UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 370 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356988![]() ((R)-1-((R)-3-(3,6- difluoro-9H- carbazol-9-yl)-2- ...) | PDB UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 826 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356992![]() ((S)-1-((R)-3-(9H- carbaxol-9-yl)-2- hydroxypropyl)...) | PDB UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 520 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356643![]() (1-cyclohexyl-3-(3- (3,6-difluoro-9H- carbazol-9-yl...) | PDB UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 284 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356648![]() (1-cyclopentyl-3-(3- (3,6-difluoro-9H- carbazol-9-y...) | PDB UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 609 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356656![]() (1-(3-(3,6-difluoro- 9H-carbazol-9-yl)-2- hydroxy-2...) | PDB UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 923 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356665![]() (1-(3-(3,6-difluoro- 9H-carbazol-9-yl)-2- hydroxy-2...) | PDB UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 541 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356684![]() (1-(3-(3,6-difluoro- 9H-carbazol-9-yl)-2- hydroxypr...) | PDB UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 438 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356693![]() (1-cyclopropyl-3-(3- (3,6-difluoro-9H- carbazol-9-y...) | PDB UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 527 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356710![]() (1-(3-(3,6-difluoro- 9H-carbazol-9-yl)-2- hydroxypr...) | PDB UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 539 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356721![]() (1-(3-(3,6-difluoro- 9H-carbazol-9-yl)-2- hydroxypr...) | PDB UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 224 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356921![]() (4-cyclopropyl-1-(3- (3,6-difluoro-9H- carbazol-9-y...) | PDB UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 420 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356932![]() ((R)-1-((R)-3-(3,6- difluoro-9H- carbazol-9-yl)-2- ...) | PDB UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 311 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356962![]() ((S)-1-((R)-3-(9H- carbazol-9-yl)-2- hydroxy-2- met...) | PDB UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 172 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356980![]() (1-(3-(9H-carbazol- 9-yl)-2- hydroxypropyl)-3- meth...) | PDB UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 462 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356986![]() ((S)-1-((R)-3-(3,6- difluoro-9H- carbazol-9-yl)-2- ...) | PDB UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 1.13E+3 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356993![]() (1-(3-(9H-carbazol- 9-yl)-2- hydroxypropyl)-3,3- di...) | PDB UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 137 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356640![]() (1-(3-(3,6-difluoro- 9H-carbazol-9-yl)-2- hydroxypr...) | PDB UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 192 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356650![]() (1-(3-(3,6-difluoro- 9H-carbazol-9-yl)-2- hydroxypr...) | PDB UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 620 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356668![]() (1-(3-(3,6-difluoro- 9H-carbazol-9-yl)-2- hydroxypr...) | PDB UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 164 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356687![]() (1-(3-(3,6-difluoro- 9H-carbazol-9-yl)-2- hydroxypr...) | PDB UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 261 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356714![]() (1-(3-(3,6-difluoro- 9H-carbazol-9-yl)-2- hydroxypr...) | PDB UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 286 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356930![]() ((S)-1-((R)-3-(3,6- difluoro-9H- carbazol-9-yl)-2- ...) | PDB UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 500 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356940![]() ((S)-1-((R)-3-(3,6- difluoro-9H- carbazol-9-yl)-2- ...) | PDB UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 302 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356947![]() (4-(3-(3,6-difluoro- 9H-carbazol-9-yl)-2- hydroxypr...) | PDB UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 738 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356958![]() ((R)-1-((R)-3-(9H- carbazol-9-yl)-2- hydroxy-2- met...) | PDB UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 535 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356992![]() ((S)-1-((R)-3-(9H- carbaxol-9-yl)-2- hydroxypropyl)...) | PDB UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 766 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356660![]() (1-(3-(3,6-difluoro- 9H-carbazol-9-yl)-2- hydroxy-2...) | PDB UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 909 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356675![]() (3-cyclopentyl-1-(3- (3,6-difluoro-9H- carbazol-9-y...) | PDB UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 338 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356680![]() (1-cyclohexyl-3-(3- (3,6-difluoro-9H- carbazol-9-yl...) | PDB UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 310 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356686![]() (1-(3-(3,6-difluoro- 9H-carbazol-9-yl)-2- hydroxypr...) | PDB UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 605 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356695![]() (1-cyclobutyl-3-(3- (3,6-difluoro-9H- carbazol-9-yl...) | PDB UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 129 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356700![]() (1-(3-(3,6-difluoro- 9H-carbazol-9-yl)-2- hydroxypr...) | PDB UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 478 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356706![]() (1-(3-(3,6-difluoro- 9H-carbazol-9-yl)-2- hydroxy-2...) | PDB UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 895 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356707![]() (1-(3-(9H-carbazol- 9-yl)-2- hydroxypropyl)-3- cycl...) | PDB UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 555 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356708![]() (1-(3-(3,6-difluoro- 9H-carbazol-9-yl)-2- hydroxypr...) | PDB UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 832 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356709![]() (1-(3-(9H-carbazol- 9-yl)-2- hydroxypropyl)-3- cycl...) | PDB UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 721 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356722![]() ((1S,4R)-2-((R)-3- (9H-carbazol-9-yl)- 2-hydroxypro...) | PDB UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 220 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356729![]() ((R)-1-((R)-3-(3,6- difluoro-9H- carbazol-9-yl)-2- ...) | PDB UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 226 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356926![]() ((R)-1-((S)-3-(9H- carbazol-9-yl)-2- hydroxypropyl)...) | PDB UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 948 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356928![]() ((R)-1-(3-(3,6- difluoro-9H- carbazol-9-yl)-2- hydr...) | PDB UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 287 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356931![]() (1-(3-(3,6-difluoro- 9H-carbazol-9-yl)-2- hydroxypr...) | PDB UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 299 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356933![]() (2-(3-(3,6-difluoro- 9H-carbazol-9-yl)-2- hydroxypr...) | PDB UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 120 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356935![]() (1-(3-(3,6-difluoro- 9H-carbazol-9-yl)-2- hydroxypr...) | PDB UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 137 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356939![]() (3-cyclobutyl-1-(3- (3,6-difluoro-9H- carbazol-9-yl...) | PDB UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 265 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356950![]() ((S)-1-((S)-3-(3,6- difluoro-9H- carbazol-9-yl)-2- ...) | PDB UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 451 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356982![]() (1-(3-(9H-carbazol- 9-yl)-2- hydroxypropyl)-4- cycl...) | PDB UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 1.03E+3 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356987![]() (1-(3-(9H-carbazol- 9-yl)-2-hydroxy-2- methylpropyl...) | PDB UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 225 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356634![]() (1-(3-(9H-carbazol- 9-yl)-2- hydroxypropyl)-3- fluo...) | PDB UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 61 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356655![]() (1-(3-(3,6-difluoro- 9H-carbazol-9-yl)-2- hydroxy-2...) | PDB UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 487 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356664![]() (1-cyclohexyl-3-(3- (3,6-difluoro-9H- carbazol-9-yl...) | PDB UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 1.19E+3 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356666![]() (1-cyclopropyl-3-(3- (3,6-difluoro-9H- carbazol-9-y...) | PDB UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 147 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356674![]() (US10214507, Compound 86) | PDB UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 497 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356691![]() (3-cyclopentyl-1-(3- (3,6-difluoro-9H- carbazol-9-y...) | PDB UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 399 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356696![]() (1-(3-(3,6-difluoro- 9H-carbazol-9-yl)-2- hydroxypr...) | PDB UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 79 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356701![]() (1-(3-(9H-carbazol- 9-yl)-2- hydroxypropyl)-3- cycl...) | PDB UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 493 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356703![]() (1-(3-(9H-carbazol- 9-yl)-2- hydroxypropyl)-3- cycl...) | PDB UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 315 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356713![]() (US10214507, Compound 102) | PDB UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 455 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356938![]() ((R)-1-((R)-3-(3,6- difluoro-9H- carbazol-9-yl)-2- ...) | PDB UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 184 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356943![]() (1-(3-(3,6-difluoro- 9H-carbazol-9-yl)-2- hydroxypr...) | PDB UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 1.34E+3 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356952![]() ((R)-1-((S)-3-(3,6- difluoro-9H- carbazol-9-yl)-2- ...) | PDB UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 958 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356961![]() (1-(3-(3,6-difluoro- 9H-carbazol-9-yl)-2- hydroxy-2...) | PDB UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 986 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Period circadian protein homolog 2 (Homo sapiens (Human)) | BDBM356969![]() (2-(3-(9H-carbazol- 9-yl)-2- hydroxypropyl)-4- meth...) | PDB UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 710 | n/a | n/a | n/a | n/a |
Reset Therapeutics, Inc. US Patent | Assay Description Compounds were screened by using a high-throughput circadian assay system as previously described in Zhang, E. E. et al. Cell, 2009, 139, 199-210. In... | US Patent US10214507 (2019) | |||||||||||
More data for this Ligand-Target Pair |